Literature DB >> 33670461

Outcomes of Lower Extremity Endovascular Revascularization: Potential Predictors and Prevention Strategies.

Federico Biscetti1,2, Elisabetta Nardella3, Maria Margherita Rando1,2, Andrea Leonardo Cecchini3, Antonio Gasbarrini1,3, Massimo Massetti1,4, Andrea Flex1,2,3.   

Abstract

Peripheral artery disease (PAD) is a manifestation of atherosclerosis, which may affect arteries of the lower extremities. The most dangerous PAD complication is chronic limb-threatening ischemia (CLTI). Without revascularization, CLTI often causes limb loss. However, neither open surgical revascularization nor endovascular treatment (EVT) ensure long-term success and freedom from restenosis and revascularization failure. In recent years, EVT has gained growing acceptance among all vascular specialties, becoming the primary approach of revascularization in patients with CLTI. In clinical practice, different clinical outcomes after EVT in patients with similar comorbidities undergoing the same procedure (in terms of revascularization technique and localization of the disease) cause unsolved issues that need to be addressed. Nowadays, risk management of revascularization failure is one of the major challenges in the vascular field. The aim of this literature review is to identify potential predictors for lower extremity endovascular revascularization outcomes and possible prevention strategies.

Entities:  

Keywords:  chronic limb-threatening ischemia (CLTI); peripheral artery disease (PAD); revascularization

Mesh:

Year:  2021        PMID: 33670461      PMCID: PMC7922574          DOI: 10.3390/ijms22042002

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  159 in total

1.  Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty.

Authors:  K Cassar; I Ford; M Greaves; P Bachoo; J Brittenden
Journal:  Br J Surg       Date:  2005-02       Impact factor: 6.939

Review 2.  Functional ambulatory status as a potential adjunctive decision-making tool following wound, level of ischemia, and severity of foot infection assessment.

Authors:  Tanzim Khan; Anastasia Plotkin; Gregory A Magee; Laura Shin; Stephanie L Woelfel; Kenneth R Ziegler; Chia Ding Shih; Fred A Weaver; David G Armstrong; Vincent L Rowe
Journal:  J Vasc Surg       Date:  2020-04-06       Impact factor: 4.268

Review 3.  Lower-extremity peripheral arterial disease among patients with end-stage renal disease.

Authors:  Ann O'Hare; Kirsten Johansen
Journal:  J Am Soc Nephrol       Date:  2001-12       Impact factor: 10.121

4.  Mechanisms of restenosis after coronary intervention: difference between plain old balloon angioplasty and stenting.

Authors:  Masaki Nakatani; Youichi Takeyama; Masayuki Shibata; Minoru Yorozuya; Hiroshi Suzuki; Shinji Koba; Takashi Katagiri
Journal:  Cardiovasc Pathol       Date:  2003 Jan-Feb       Impact factor: 2.185

5.  Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus.

Authors:  Elizabeth Selvin; Spyridon Marinopoulos; Gail Berkenblit; Tejal Rami; Frederick L Brancati; Neil R Powe; Sherita Hill Golden
Journal:  Ann Intern Med       Date:  2004-09-21       Impact factor: 25.391

6.  Usefulness of high mobility group box 1 protein as a plasma biomarker in patient with peripheral artery disease.

Authors:  Susumu Oozawa; Shunji Sano; Masahiro Nishibori
Journal:  Acta Med Okayama       Date:  2014       Impact factor: 0.892

7.  An early validation of the Society for Vascular Surgery lower extremity threatened limb classification system.

Authors:  David L Cull; Ginger Manos; Michael C Hartley; Spence M Taylor; Eugene M Langan; John F Eidt; Brent L Johnson
Journal:  J Vasc Surg       Date:  2014-10-03       Impact factor: 4.268

Review 8.  Adipose tissue dysfunction in obesity, diabetes, and vascular diseases.

Authors:  Gideon R Hajer; Timon W van Haeften; Frank L J Visseren
Journal:  Eur Heart J       Date:  2008-09-05       Impact factor: 29.983

9.  Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS).

Authors:  Ann M O'Hare; Eric Vittinghoff; Judith Hsia; Michael G Shlipak
Journal:  J Am Soc Nephrol       Date:  2004-04       Impact factor: 10.121

10.  Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort.

Authors:  Jung-Joon Cha; Hyoeun Kim; Young-Guk Ko; Donghoon Choi; Jae-Hwan Lee; Chang-Hwan Yoon; In-Ho Chae; Cheol Woong Yu; Seung Whan Lee; Sang-Rok Lee; Seung Hyuk Choi; Yoon Seok Koh; Pil-Ki Min
Journal:  Cardiovasc Diabetol       Date:  2020-06-22       Impact factor: 9.951

View more
  7 in total

1.  The Role of Endovascular Procedure for Peripheral Arterial Disease in Diabetic Patients With Chronic Limb-Threatening Ischemia.

Authors:  Yudistira Santosa; Azizah Dhena Harca; Edwin Sukmaja; Angelina Yuwono
Journal:  Cureus       Date:  2022-04-05

2.  The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization.

Authors:  Nikolaos P E Kadoglou; Emmanouil Korakas; Christos Karkos; Eirini Maratou; Ioannis Kanonidis; Panagiotis Plotas; Nikolaos Papanas; Paraskevi Moutsatsou; Ignatios Ikonomidis; Vaia Lambadiari
Journal:  Cardiovasc Diabetol       Date:  2021-11-10       Impact factor: 9.951

Review 3.  Gene Therapy of Chronic Limb-Threatening Ischemia: Vascular Medical Perspectives.

Authors:  Florian Simon; Mansur Duran; Waseem Garabet; Hubert Schelzig; Michael Jacobs; Alexander Gombert
Journal:  J Clin Med       Date:  2022-02-26       Impact factor: 4.241

4.  Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease.

Authors:  Nikolaos P E Kadoglou; Dimitrios Kapetanios; Emmanouil Korakas; Georgia Valsami; Nikolaos Tentolouris; Nikolaos Papanas; Vaia Lambadiari; Christos Karkos
Journal:  Cardiovasc Diabetol       Date:  2022-09-01       Impact factor: 8.949

Review 5.  Advances for the treatment of lower extremity arterial disease associated with diabetes mellitus.

Authors:  Yang Pan; Yuting Luo; Jing Hong; Huacheng He; Lu Dai; Hong Zhu; Jiang Wu
Journal:  Front Mol Biosci       Date:  2022-08-17

6.  Serum high mobility group box-1 levels associated with cardiovascular events after lower extremity revascularization: a prospective study of a diabetic population.

Authors:  Maria Margherita Rando; Federico Biscetti; Andrea Leonardo Cecchini; Elisabetta Nardella; Maria Anna Nicolazzi; Flavia Angelini; Roberto Iezzi; Luis H Eraso; Paul J Dimuzio; Dario Pitocco; Antonio Gasbarrini; Massimo Massetti; Andrea Flex
Journal:  Cardiovasc Diabetol       Date:  2022-10-16       Impact factor: 8.949

7.  Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons.

Authors:  Estefanny Villar-Matamoros; Lauren Stokes; Alyssa Lloret; Meagan Todd; Bryan W Tillman; Saami K Yazdani
Journal:  J Cardiovasc Pharmacol Ther       Date:  2022 Jan-Dec       Impact factor: 2.807

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.